3-[3-(4-Morpholin-4-yl-1-benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxycyclobutan-1-amine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 英文名称: 3-[3-(4-Morpholin-4-yl-1-benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxycyclobutan-1-amine
• 英文别名: 3-[3-(4-morpholin-4-yl-1-benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]oxycyclobutan-1-amine
• 化学式: C₂₂H₂₃N₅O₃
• 分子量: 405.4
• InChiKey: PGGBHJFCSGTEII-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  30
• 可旋转键数：
  4
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  91
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• SUBSTITUTED-IMIDAZOPYRIDAZINES
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20160287589A1

  公开（公告）日：2016-10-06

  The present invention relates to amido-substituted imidazopyridazine compounds of general formula (I): (Ia) (Ib) (Ic) (Id) in which A, Y, R1, R2, R3, R4 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.